DOC SNGL DIP BUPRENORPHINEItem Cross Reference: PG-PDA-01BP5 and 4 more items

Premier Biotech has been awarded contract PO05427605 by the Virginia Department of Corrections' Correctional Enterprises division, effective August 3, 2026. The contract establishes a cumulative value of $16,532.75 for the supply of drug screening and testing products. The awarded line items include single-dip drug testing devices for buprenorphine (150 units at $0.49 each), cocaine (250 units at $0.49 each), and oxycodone (75 units at $0.49 each), as well as rapid ethyl glucuronide (EtG) single-dip alcohol screening tests for the Department of Juvenile Justice (150 units at $4.50 each). All products are designated for delivery to the Manager at the contracting organization.

The contract also includes a substantial component of multi-panel urine drug screening cups, with 3,125 thirteen-panel urine cups ordered at $5.00 per unit, representing the largest line item by volume and value. These testing supplies are intended to support substance abuse screening and monitoring programs within Virginia's correctional and juvenile justice facilities. The products are standard clinical diagnostic tools used for institutional drug screening operations.